You are here: Industry Insights > Cardiovascular disease

News List

Research Progress in Signaling Pathway and Related Drugs of Target GDF15 Xiaonisha/PharmaSources
April 19, 2023
GDF15 being a kind of endocrine hormone and a member of transforming growth factor β superfamily, acts as an autocrine regulatory molecule in macrophages, which was identified and found from the clone of activated macrophage cell line.
Aspirin is linked with increased risk of heart failure WorldPharmaNews
November 24, 2021
Aspirin use is associated with a 26% raised risk of heart failure in people with at least one predisposing factor for the condition. That’s the finding of a study published today in ESC Heart Failure, a journal of the European Society of Cardiology (ESC).
AHA News: How Technology Is Improving Health Information Access for the Deaf Community drugs
July 13, 2021
Early in Dr. Michael McKee's career, one of his patients, who was deaf, died from a heart attack. It led him to study how to prevent it from happening to others.
AHA News: Surprisingly Few Women May Have Good Heart Health Before Pregnancy drugs
May 27, 2021
Less than half of U.S. women entering pregnancy have good heart health, and those rates are falling, according to new research.
Discrimination May Change Heart Structure in Hispanic Adults drugs
May 24, 2021
Hispanic adults who experience perceived discrimination are more likely to have changes in the structure of their heart that may lead to cardiovascular disease, according to new research.
AZ sells rights to statin med Crestor to Grünenthal pharmatimes
December 01, 2020
AstraZeneca (AZ) has announced that it will sell the rights to statin medication Crestor to Grünenthal in over 30 European countries.
Re-purposed drugs could reverse blood vessel damage in diabetes expresspharma
June 30, 2020
In a breakthrough, scientists have discovered a key mechanism that triggers changes in the blood vessels, which can eventually lead to cardiovascular disease.
Cleveland Clinic researchers discover a new diet-associated gut-microbe metabolite linked to cardiovascular disease expresspharma
March 17, 2020
Discovery could help explain why beta-blockers are effective in treating heart disease patients.
Major Cardiovascular Diseases May Up Long-Term Risk for ESKD drugs
January 15, 2020
Major incident cardiovascular disease events are associated with an increased risk for end-stage kidney disease (ESKD), with the highest risk for heart failure, according to a study published online January in the Journal of the American Society of Nephro
Dulaglutide reduces cardiovascular disease in Type-2 diabetic people biospectrumasia
June 10, 2019
This international, double-blind randomized controlled trial enrolled 9,901 people, age 50 and older with T2D from 24 countries at 371 care centers.

Previous page 1 2 3 Next page